Pancreatic islet cell antigens obtained by molecular cloning

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530325, 530376, 530350, C07K 14705

Patent

active

058408363

ABSTRACT:
Pancreatic islet cell antigens (ICA) that bind with antibodies found in the sera of patients afflicted with insulin-dependent (Type I) diabetes mellitus (IDDM). ICA proteins are expressed by recombinant cloning vehicles comprising DNA inserts isolated from islet cells. Full sequence native ICA proteins, or protein or peptide fragments thereof, can be used in the diagnosis of IDDM and in detecting or blocking human immunoglobulin, T-cells, or B-cells involved in IDDM.

REFERENCES:
patent: 5200318 (1993-04-01), Rabin et al.
Srikanta et al. (1986) Mol. Biol. Med 3:113-127.
Karounos et al. (1988) Diabetes 37(5) :30A.
Moncayo et al. (1988) Diabetologia 31(7) :523A.
Glover (1984) "Principles of Cloning DNA" Gene Cloning pp. 1-19.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pancreatic islet cell antigens obtained by molecular cloning does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pancreatic islet cell antigens obtained by molecular cloning, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pancreatic islet cell antigens obtained by molecular cloning will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1703273

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.